These observations suggest that the inhibitory effect of honokiol on lung cancer cell migration is mediated, at least in part, through the downregulation of COX-2 expression and PGE2 production, which are the downstream targets of NF-κB. This evidence concerns the gene PTGS2 and lung carcinoma.